Objectives: This study is aimed at evaluating androgen receptor (AR) and tumor-associated neutrophil (TAN) expressions in different breast cancer subtypes and their relationship with tumor differentiation, stage, and other clinicopathological markers. This evidence concerns the gene AR and neoplasm.